Campylobacter jejuni virulence genes (C. jejuni virulence genes)

Campylobacter jejuni virulence genes encode a diverse array of proteins essential for the pathogen's ability to colonize the host, evade the immune system, and induce disease. Key factors include flagellar proteins (FlaA/B) for motility, adhesins (CadF, FlpA) for attachment to intestinal epithelial cells, and the cytolethal distending toxin (CDT) which induces host cell cycle arrest and apoptosis (Dasti et al., 2010, PMID: 20413311). These genes are critical for the pathogenesis of campylobacteriosis, a leading cause of bacterial diarrhea worldwide, and are also linked to post-infectious complications like Guillain-Barré syndrome due to molecular mimicry between bacterial components and human nerves (Yuki et al., 2004, PMID: 15044480). While traditional antibiotics like azithromycin target the bacterial ribosome rather than these specific genes, the virulence factors themselves are increasingly explored as targets for novel anti-virulence therapies. Such therapies aim to neutralize the pathogen's harmful effects, such as toxin activity or adhesion, without the selective pressure and microbiota disruption associated with broad-spectrum antibiotics (Backert et al., 2013, PMID: 23533469). Research into these genes also informs vaccine development, focusing on highly conserved surface-exposed proteins to provide broad protection against various strains.

Other names

Campylobacter jejuni virulence factorsC. jejuni pathogenicity factorsCampylobacter virulence determinants

Standard antibiotics like macrolides (Azithromycin) inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, while fluoroquinolones (Ciprofloxacin) inhibit DNA gyrase; experimental anti-virulence strategies aim to specifically inhibit the function of virulence proteins such as the cytolethal distending toxin or adhesins like CadF.